Silica particles for nucleic acid encapsulation

Summary:

A Spanish healthcare research institute has developed silica particles for nucleic acid encapsulation, which are able to transport and transfer gen therapies and proteins into cells. In addition, they are stable at room temperature, versatile and cost-effective.

The Institute is looking for companies interested in the use of this patent protected silica particles to cooperate in the framework of a commercial agreement with technical assistance or a research and development agreement.

Reference: TOES20230331019

Country: Spain

Submitted: 3. 4. 2023

View Partnering Opportunity

Keywords

Technology: Biological Nanomaterials; Cellular and Molecular Biology; Human vaccines; Gene Expression, Proteome Research; Gene - DNA Therapy.

Market: Micro- and Nanotechnology related to Biological sciences; Cellular and Molecular Biology; Gene Expression, Proteome Research; Genetic Engineering; Molecular design.

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.